Efficacy and Safety of Brodalumab in Adolescents From 12 to 17 Years of Age With Moderate-to-severe Plaque Psoriasis
Clinical trial NCT04305327 · TERMINATED
Trial details
- NCT number
- NCT04305327
- Sponsor
- LEO Pharma
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-12-07
- Primary completion
- 2023-05-05
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.